Mark Ostrowski work email
- Valid
Mark Ostrowski personal email
- Valid
STRATEGY | CAPITAL FORMATION | BOARD ADVISORY | GROWTH | M&A | LEAN START-UP | JOINT VENTURES | LICENSING | PRODUCT DEVELOPMENT | COMMERCIALIZATION | HEALTHCARE | REIMBURSEMENT | OPERATIONS | TURNAROUND | MANAGEMENT CONSULTING | INTERNATIONAL Accomplished biotechnology/molecular diagnostics executive and successful private investor. Recognized for leadership, strategy and commercial execution with global experience across North America, Europe, and Asia Pacific. Leader, coach and mentor skilled in building and motivating high-performing cross-functional teams to deliver consistently strong results for shareholders. Partnering with C-level managers and Board members to create business plans, attract talent, implement change, drive growth, source funding, and support board-level initiatives.Deep experience as a commercial operations and sales/marketing leader for both public and private clinical molecular diagnostics companies, focused primarily in oncology and women's health. Specializing in early-stage strategic planning and capital formation, and commercialization and growth strategy as part of startup, early-stage and turnaround business scenarios.Specialties:* Capital formation and M&A* Due-Diligence Market Research & SWOT/GAP Trend Analyses* Go-to-Market and Growth Strategies, Channel Management and Strategic Partnering* Domestic & ex-US Sales Organization Design, Recruitment and Training* Senior Executive, Board, and KOL/Scientific Advisory Board Recruitment in Molecular Diagnostics, Personalized Medicine, and Digital Healthcare
Vested Capital Partners
-
General PartnerVested Capital Partners 2015 - PresentVested Capital Partners specializes in providing a broad range of corporate advisory and merchant banking services to clients in emerging growth industries, principally in the life sciences, technology, and healthcare markets.Vested Capital Partners provides business advisory services, investment capital and fractional CxO support to both private and public corporations. We provide strategic consulting advice and structure privately-negotiated equity investments and strategic corporate partnerships. We bring a strong track record of successful transactions and an extensive network of corporate and financial relationships more typically found in much larger investment banking advisory firms.
-
Svp, Sales And MarketingPhenogen Sciences, Inc. 2012 - 2015
-
President And Chief Operating OfficerSera Prognostics Apr 2011 - Mar 2012Salt Lake City, Ut, UsSera Prognostics is a private biotechnology company developing diagnostic tests that use proprietary biomarkers that are predictive of preterm birth and other pregnancy complications. Sera was founded in 2008 and licensed its serum proteomics discovery technology and novel peptides from Brigham Young University and the University of Utah. The company has assembled a board of directors and management team with significant clinical development and women’s healthcare diagnostic experience for translating scientific innovation into commercial products that help healthcare practitioners provide more effective, personalized care for expecting mothers and their newborns. -
PrincipalExcella Bioscience Consulting Llc Dec 2009 - Mar 2012Commercialization and growth strategy management consulting, interim management, and capital formation services and financing for startup and early-stage biotechnology, medical device, healthcare and technology companies.
-
Senior Vice President, Sales & MarketingPerlegen Sciences Jan 2009 - Nov 2009UsPerlegen Sciences, Inc. is a clinical molecular diagnostics company and CLIA laboratory focused on delivering clinically useful diagnostic tests to assist oncology and women's health providers in the clinical decision-making process, improving patient treatment outcomes. **Perlegen ceased operations in November 2009, due to lack of funding, prior to the commercial launch of its sporadic breast cancer genetic+clinical risk stratification assay, developed in association with Cancer Research UK and the University of Cambridge. [***In April 2010, Genetic Technologies Group (NASDAQ: GENE) of Melbourne, Australia acquired Perlegen's BREVAGen, a sporadic breast cancer risk stratification test.] -
Vp, Global Sales And MarketingGenvault Corporation Jan 2008 - Jan 2009UsGenVault is an emerging life sciences company delivering innovative, sustainable biobanking and biosample management solutions for genomic discovery and translational research. Their biosample storage, transport and retrieval matrices are dry-state, room-temperature technologies which do not require traditional cryopreservation, thereby eliminating unnecessary and wasteful energy and floor-space consumption (i.e., ultra-low temperature freezers). As VP, Global Sales and Marketing, I was responsible for an international commercial organization covering the US, Canada, Europe, Middle East and Asia/Pacific. **In February 2011, GenVault was acquired by IntegenX, of Pleasanton, CA. -
Director Of Sales OperationsMyriad Genetics Jan 2003 - Jan 2008Salt Lake City, Utah, UsI was a founding member of the sales management team at Myriad Genetics/Myriad Genetic Laboratories, Inc., a NASDAQ-listed world-leader in predictive medicine and cancer susceptibility genetic testing, where I helped lead the dramatic growth of that organization from $2 million to ~$200 million in annual revenues over a 10-year period. -
Northeast Area ManagerMyriad Genetics Nov 1997 - Jan 2003Salt Lake City, Utah, UsI was a founding member of Myriad's sales and then sales management staff, where I managed a top-producing area sales team of between eight and eleven account executives over a four-year period, with annual sales growth ranging from between 87 - 122% year-over-year, over a four-year period.
Mark Ostrowski Skills
Mark Ostrowski Education Details
-
Yale UniversityMolecular Biophysics And Biochemistry
Frequently Asked Questions about Mark Ostrowski
What company does Mark Ostrowski work for?
Mark Ostrowski works for Vested Capital Partners
What is Mark Ostrowski's role at the current company?
Mark Ostrowski's current role is Investor | Entrepreneur | CXO | Life Sciences | Tech | Investment Banking.
What is Mark Ostrowski's email address?
Mark Ostrowski's email address is ma****@****hoo.com
What schools did Mark Ostrowski attend?
Mark Ostrowski attended Yale University.
What are some of Mark Ostrowski's interests?
Mark Ostrowski has interest in Mobile, Response, Clinical Trials, Channel, Screening, Molecular Diagnostics, Sales, Prostate, Biomarker, Breakthrough.
What skills is Mark Ostrowski known for?
Mark Ostrowski has skills like Oncology, Commercialization, Medical Devices, Lifesciences, Biotechnology, Genetics, Market Development, Molecular Diagnostics, Start Ups, Genomics, Managed Care, Cancer.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial